Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.61 |
| ▸ | HPGD | P15428 | 6/20 | 0.61 |
| ▸ | MAPT | P10636 | 5/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.61 |
| ▸ | GAA | P10253 | 3/20 | 0.61 |
| ▸ | MEN1 | O00255 | 3/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.61 |
| ▸ | GLA | P06280 | 2/20 | 0.61 |
| ▸ | ATM | Q13315 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | CISD2 | Q8N5K1 | 3/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | CFTR | P13569 | 1/20 | 0.46 |
| ▸ | GRM6 | O15303 | 1/20 | 0.45 |
| ▸ | GRM5 | P41594 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 3/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4651650 | 0.80 | LMNA (0.56) | ALDH1A1HPGDMAPTKDM4EHSD17B10 | |
| SCHEMBL11328828 | 0.79 | MCL1 (0.48) | ALDH1A1HPGDMAPTKDM4EHSD17B10 | |
| SCHEMBL1101766 | 0.76 | KDM4E (1.00) | ALDH1A1HPGDMAPTKDM4EHSD17B10 | |
| SCHEMBL30173777 | 0.76 | KDM4E (1.00) | ALDH1A1HPGDMAPTKDM4EHSD17B10 | |
| SCHEMBL6656348 | 0.72 | LMNA (0.69) | ALDH1A1HPGDMAPTKDM4EHSD17B10 | |
| SCHEMBL9495325 | 0.70 | LMNA (1.00) | ALDH1A1HPGDMAPTKDM4EHSD17B10 | |
| SCHEMBL31347574 | 0.70 | MAPK1 (0.71) | ALDH1A1HPGDMAPTKDM4EHSD17B10 | |
| SCHEMBL1031488 | 0.70 | LMNA (0.71) | ALDH1A1HPGDMAPTKDM4EHSD17B10 | |
| SCHEMBL4651653 | 0.70 | MAPK1 (0.71) | ALDH1A1HPGDMAPTKDM4EHSD17B10 | |
| SCHEMBL431794 | 0.70 | MAPT (0.74) | ALDH1A1HPGDMAPTKDM4EHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105884803-B | Compound and its application for organic optoelectronic device | 三星SDI株式会社 | 2019-10-18 | — | — | CN | disclosed |
| EP-3056498-B1 | DIAZADIBENZOFURANE AND DIAZADIBENZOTHIOPHENE DERIVATIVES AND THEIR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG SDI CO LTD (KR) | 2018-09-19 | — | — | EP | disclosed |
| CN-105884803-A | Compound For Organic Optoelectronic Device And Application Thereof | 三星SDI株式会社 | 2016-08-24 | — | — | CN | disclosed |
| US-20160240791-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE | SAMSUNG SDI CO., LTD. (KR) | 2016-08-18 | — | — | US | disclosed |
| EP-3056498-A1 | DIAZADIBENZOFURANE AND DIAZADIBENZOTHIOPHENE DERIVATIVES AND THEIR USE IN ORGANIC OPTOELECTRONIC DEVICES | Samsung SDI Co., Ltd. (KR) | 2016-08-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160240791-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE | OR10J3, OXER1, OCIAD1 | ALDH1A1 63/4885HPGD 625/4885MAPT 2194/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.